Safety and efficacy of the addition of simvastatin to panitumumab in previously treated KRAS mutant metastatic colorectal cancer patients

Author(s):
Baas, J.M.; Krens, L.L.; Bos, M.M.; Portielje, J.E.A.; Batman, E.; Wezel, T. van; Morreau, H.; Guchelaar, H.J. (0000-0002-7085-1383); Gelderblom, H.
Published
2015
Publication type
Article / Letter to editor
colorectal cancerKRASpanitumumabstatin
Date issued
2015-09-30
Language
English
Is part of
Anti-Cancer Drugs (2015), Vol. 26, no. 8, p. 872-877
hdl
1887/107023
doi
10.1097/CAD.0000000000000255